Evidence map›Paper›PMID 22805753›Full record

ReviewOral diseases2013

Current cell models for bioengineering a salivary gland: a mini-review of emerging technologies.

J Nelson, K Manzella, O J Baker

Open access · bronzeAbstract readReview
In one paragraph

Review in Oral diseases, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Salivary Gland Bioengineering.Bioengineering (Basel, Switzerland) · 2023
    Review
  3. Bioengineering in salivary gland regeneration.Journal of biomedical science · 2022
    Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. JAK Inhibitors and Oxidative Stress Control.Frontiers in immunology · 2019
    Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Defining periodontal health.BMC oral health · 2015
    Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

J NelsonDepartment of Oral Biology, School of Dental Medicine, University at Buffalo, The State University of New York, Buffalo, NY, USA.
K Manzella
O J Baker
University at Buffalo, State University of New York · US

Funding

THE USE OF FIBRIN HYDROGELS TO PROMOTE SALIVARY GLAND REGENERATIONR01DE022971 · NIDCR · UNIVERSITY OF UTAH · PI ANDREADIS, STELIOS T., BAKER, OLGA JULIANA · 2012 to 2025
$7.2M
Resolution of Cytokine-Mediated Salivary Gland InflammationR01DE021697 · NIDCR · UNIVERSITY OF UTAH · PI BAKER, OLGA JULIANA · 2012 to 2016
$2.3M
Effect of SS-associated cytokines on salivary gland dysfunctionR21DE019721 · NIDCR · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI BAKER, OLGA JULIANA · 2010 to 2011
$418k
NIDCR NIH HHS R01 DE021697NIDCR NIH HHS R01-DE021697-01A1NIDCR NIH HHS R01 DE022971NIDCR NIH HHS R21 DE019721NIDCR NIH HHS R21-DE19721-01A1
6 · The paper itself

Abstract

Oral Diseases (2013) 19, 236-244 Saliva plays a major role in maintaining oral health. Patients afflicted with a decrease in saliva secretion (symptomatically, xerostomia) exhibit difficulty in chewing and swallowing foods, tooth decay, periodontal disease, and microbial infections. Despite recent improvements in treating xerostomia (e.g., saliva stimulants, saliva substitutes, and gene therapy), there is a need of more scientific advancements that can be clinically applied toward restoration of compromised salivary gland function. Here we provide a summary of the current salivary cell models that have been used to advance restorative treatments via development of an artificial salivary gland. These models represent initial steps toward clinical and translational research, to facilitate creation of clinically safe salivary glands. Further studies in salivary cell lines and primary cells are necessary to improve survival rates, cell differentiation, and secretory function. Additionally, the characterization of salivary progenitor and stem cell markers are necessary. Although these models are not fully characterized, their improvement may lead to the construction of an artificial salivary gland that is in high demand for improving the quality of life of many patients suffering from salivary secretory dysfunction.

Indexed as

Cell EngineeringModels, BiologicalSalivary GlandsCell Line, TumorHumansStem Cellscell lineprimary cultureprogenitor cellssalivary gland dysfunction

Identifiers

PMID22805753
PMCPMC3477256
OpenAlexW1597887123

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.